Prostatic cancer, castration-resistant
Clinical trials for Prostatic cancer, castration-resistant explained in plain language.
Never miss a new study
Get alerted when new Prostatic cancer, castration-resistant trials appear
Sign up with your email to follow new studies for Prostatic cancer, castration-resistant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough prostate cancer: drug combo trial launches
Disease control OngoingThis Phase II trial tests a new drug, JSB462 (luxdegalutamide), combined with a radioactive therapy (Pluvicto) in 138 men with PSMA-positive metastatic castration-resistant prostate cancer that has progressed after prior treatments. The study aims to see if the combination works …
Matched conditions: PROSTATIC CANCER, CASTRATION-RESISTANT
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can targeted radiation slow prostate cancer that resists hormone therapy?
Disease control OngoingThis trial tests whether high-dose radiation aimed at a few cancer spots can slow the disease in men with prostate cancer that has stopped responding to hormone therapy. Half the participants receive radiation to their metastases, while the other half are watched without immediat…
Matched conditions: PROSTATIC CANCER, CASTRATION-RESISTANT
Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC